NEW YORK (GenomeWeb News) - Shares in Illumina were up more than 29 percent, or $8.42, at $37.28 in mid-afternoon trading after the company reported strong second-quarter earnings.
As GenomeWeb News reported this morning, Illumina reported a 163-percent surge in second-quarter revenues and swung into profitability from a loss in the second quarter of 2005.
Registering provides access to this and other free content.
Already have an account?Login Now.
Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.
The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.
In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.
Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.